| Product Code: ETC13279194 | Publication Date: Apr 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 150 | No. of Figures: 55 | No. of Tables: 32 |
North America HER2 Testing Market |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 North America HER2 Testing Market Overview |
3.1 North America Regional Macro Economic Indicators |
3.2 North America HER2 Testing Market Revenues & Volume, 2021 & 2031F |
3.3 North America HER2 Testing Market - Industry Life Cycle |
3.4 North America HER2 Testing Market - Porter's Five Forces |
3.5 North America HER2 Testing Market Revenues & Volume Share, By Countries, 2021 & 2031F |
3.6 North America HER2 Testing Market Revenues & Volume Share, By Technique, 2021 & 2031F |
3.7 North America HER2 Testing Market Revenues & Volume Share, By Cancer Type, 2021 & 2031F |
3.8 North America HER2 Testing Market Revenues & Volume Share, By End-user, 2021 & 2031F |
4 North America HER2 Testing Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 North America HER2 Testing Market Trends |
6 North America HER2 Testing Market, 2021 - 2031 |
6.1 North America HER2 Testing Market, Revenues & Volume, By Technique, 2021 - 2031 |
6.1.1 Overview & Analysis |
6.1.2 North America HER2 Testing Market, Revenues & Volume, By Fluorescence In Situ Hybridization, 2021 - 2031 |
6.1.3 North America HER2 Testing Market, Revenues & Volume, By Dual-Probe, 2021 - 2031 |
6.1.4 North America HER2 Testing Market, Revenues & Volume, By Single-Probe, 2021 - 2031 |
6.1.5 North America HER2 Testing Market, Revenues & Volume, By Chromogenic In Situ Hybridization (CISH), 2020 - 2028 |
6.1.6 North America HER2 Testing Market, Revenues & Volume, By Silver-Enhanced In Situ Hybridization, 2020 - 2028 |
6.2 North America HER2 Testing Market, Revenues & Volume, By Cancer Type, 2021 - 2031 |
6.2.1 Overview & Analysis |
6.2.2 North America HER2 Testing Market, Revenues & Volume, By Breast Cancer, 2021 - 2031 |
6.2.3 North America HER2 Testing Market, Revenues & Volume, By Gastric Cancer, 2021 - 2031 |
6.3 North America HER2 Testing Market, Revenues & Volume, By End-user, 2021 - 2031 |
6.3.1 Overview & Analysis |
6.3.2 North America HER2 Testing Market, Revenues & Volume, By Hospitals, 2021 - 2031 |
6.3.3 North America HER2 Testing Market, Revenues & Volume, By Diagnostic Laboratories, 2021 - 2031 |
6.3.4 North America HER2 Testing Market, Revenues & Volume, By Others, 2021 - 2031 |
7 North America HER2 Testing Market, By Countries, 2021 - 2031 |
7.1 Overview & Analysis |
7.2 North America HER2 Testing Market, Revenues & Volume, By Technique, 2021 - 2031 |
7.2.1 United States (US) HER2 Testing Market, Revenues & Volume, By Technique, 2021 - 2031 |
7.2.2 Canada HER2 Testing Market, Revenues & Volume, By Technique, 2021 - 2031 |
7.2.3 Rest of North America HER2 Testing Market, Revenues & Volume, By Technique, 2021 - 2031 |
7.3 North America HER2 Testing Market Revenues & Volume Share, By Cancer Type, 2021 & 2031F |
7.3.1 United States (US) HER2 Testing Market, Revenues & Volume, By Cancer Type, 2021 - 2031 |
7.3.2 Canada HER2 Testing Market, Revenues & Volume, By Cancer Type, 2021 - 2031 |
7.3.3 Rest of North America HER2 Testing Market, Revenues & Volume, By Cancer Type, 2021 - 2031 |
7.4 North America HER2 Testing Market, Revenues & Volume, By End-user, 2021 - 2031 |
7.4.1 United States (US) HER2 Testing Market, Revenues & Volume, By End-user, 2021 - 2031 |
7.4.2 Canada HER2 Testing Market, Revenues & Volume, By End-user, 2021 - 2031 |
7.4.3 Rest of North America HER2 Testing Market, Revenues & Volume, By End-user, 2021 - 2031 |
8 North America HER2 Testing Market Key Performance Indicators |
9 North America HER2 Testing Market - Export/Import By Countries Assessment |
10 North America HER2 Testing Market - Opportunity Assessment |
10.1 North America HER2 Testing Market Opportunity Assessment, By Countries, 2021 & 2031F |
10.2 North America HER2 Testing Market Opportunity Assessment, By Technique, 2021 & 2031F |
10.3 North America HER2 Testing Market Opportunity Assessment, By Cancer Type, 2021 & 2031F |
10.4 North America HER2 Testing Market Opportunity Assessment, By End-user, 2021 & 2031F |
11 North America HER2 Testing Market - Competitive Landscape |
11.1 North America HER2 Testing Market Revenue Share, By Companies, 2022 |
11.2 North America HER2 Testing Market Competitive Benchmarking, By Operating and Technical Parameters |
12 Top 10 Company Profiles |
13 Recommendations |
14 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here